(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets's offering.
The report contains a comprehensive listing of distribution deals announced since 2020, as recorded in the Current Agreements deals and alliances database, including financial terms where available. It also provides links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners. This collection offers critical insight into the structure and terms of each deal.

Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals. Fully revised and updated, the report provides details of distribution deals from 2020 to 2025. The report provides access to distribution deal payment terms as announced between the parties.

This data provides useful insight into the payment and other deal terms. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities. Chapter 1 introduces the report, and chapter 2 offers an overview of trends in distribution, discussing the merits of different deal types. Chapter 3 outlines the structure of distribution deals. Chapter 4 reviews leading distribution deals since 2020, listed by headline value, and offers links to the SEC-recorded agreements. Chapter 5 lists the top 25 most active distribution dealmaker companies, linking to the full deal records and contract documents if available via the Current Agreements deals and alliances database. Chapter 6 offers a detailed review of distribution deals organized by company A-Z, therapy, technology, and industry type signed and announced since 2020, providing an in-depth look at the actual deal terms agreed upon between the parties.

Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in distribution dealmaking
2.1. Introduction
2.2. Definition of distribution deals
2.3. Trends in distribution deals since 2020
2.3.1. Distribution dealmaking by year, 2020-2025
2.3.2. Distribution dealmaking by phase of development, 2020-2025
2.3.3. Distribution dealmaking by industry sector, 2020-2025
2.3.4. Distribution dealmaking by therapy area, 2020-2025
2.3.5. Distribution dealmaking by technology type, 2020-2025
2.3.6. Distribution dealmaking by most active company, 2020-2025
2.3.7. Attributes of pure distribution deals
2.3.8. Attributes of distribution in multi-component deals
2.4. Aligning partners to make the distribution agreement work
Chapter 3 - Overview of distribution deal structure
3.1. Introduction
3.2. Distribution agreement structure
3.3. Distribution rights as part of a wider alliance agreement
Chapter 4 - Leading distribution deals
4.1. Introduction
4.2. Top distribution deals by value
Chapter 5 - Top 25 most active distribution dealmakers
5.1. Introduction
5.2. Top 25 most active distribution dealmakers
Chapter 6 - Distribution deals including contracts directory
6.1. Introduction
6.2. Distribution deals with contracts 2020-2025
Companies Featured

• Abbott Laboratories
• Bayer
• BioNTech
• Gilead Sciences
• Genentech
• Johnson & Johnson
• Moderna
• Novartis
• Pfizer
• Roche
• Sanofi
• Biogen
• Eli Lilly
• Amgen
• Bristol-Myers Squibb
• GlaxoSmithKline
• Merck & Co.
• AstraZeneca
• Boehringer Ingelheim
• Teva Pharmaceutical Industries
• Cardinal Health
• Catalent
• Cipla
• CSL Limited
• Daiichi Sankyo
• Dr. Reddy's Laboratories
• Fresenius
• GSK
• Hoffmann-La Roche
• Lonza
• Otsuka Pharmaceutical
• Samsung Biologics
• Sandoz
• Shionogi
• Sumitomo Dainippon Pharma
• Takeda Pharmaceutical
• UCB
• Vertex Pharmaceuticals
• WuXi AppTec
• AbbVie
• Alexion Pharmaceuticals
• Alnylam Pharmaceuticals
• Biocon
• Celgene
• Celularity
• Charles River Laboratories
• Chugai Pharmaceutical
• Jazz Pharmaceuticals
• LabCorp
• Lupin
• Regeneron Pharmaceuticals

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN18112025004107003653ID1110359550